Lemon Grove, California

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Schizophrenia

Closed trials

• Completed

  A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

  NCT05227690· Phase 2· AbbVie· Source